AgeX Therapeutics Shares Owned By Institutions vs. Total Debt

AGEDelisted Stock  USD 0.74  0.01  1.37%   
Based on AgeX Therapeutics' profitability indicators, AgeX Therapeutics may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess AgeX Therapeutics' ability to earn profits and add value for shareholders.
For AgeX Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AgeX Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AgeX Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AgeX Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AgeX Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please note, there is a significant difference between AgeX Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AgeX Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AgeX Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AgeX Therapeutics Total Debt vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining AgeX Therapeutics's current stock value. Our valuation model uses many indicators to compare AgeX Therapeutics value to that of its competitors to determine the firm's financial worth.
AgeX Therapeutics is rated below average in shares owned by institutions category among its peers. It is rated below average in total debt category among its peers making up about  773,936  of Total Debt per Shares Owned By Institutions. Comparative valuation analysis is a catch-all technique that is used if you cannot value AgeX Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

AgeX Total Debt vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

AgeX Therapeutics

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
5.64 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

AgeX Therapeutics

Total Debt

 = 

Bonds

+

Notes

 = 
4.37 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

AgeX Total Debt vs Competition

AgeX Therapeutics is rated below average in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 380.13 Million. AgeX Therapeutics claims roughly 4.37 Million in total debt contributing just under 2% to equities under Health Care industry.
Total debt  Revenue  Valuation  Capitalization  Workforce

AgeX Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in AgeX Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AgeX Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of AgeX Therapeutics' change in net profit over the period of time. It can combine multiple indicators of AgeX Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California. Agex Therapeutics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.

AgeX Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on AgeX Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AgeX Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AgeX Therapeutics' important profitability drivers and their relationship over time.

Use AgeX Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AgeX Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AgeX Therapeutics will appreciate offsetting losses from the drop in the long position's value.

AgeX Therapeutics Pair Trading

AgeX Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to AgeX Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AgeX Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AgeX Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AgeX Therapeutics to buy it.
The correlation of AgeX Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AgeX Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AgeX Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AgeX Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your AgeX Therapeutics position

In addition to having AgeX Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Growth Funds Thematic Idea Now

Large Growth Funds
Large Growth Funds Theme
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in AgeX Stock

If you are still planning to invest in AgeX Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AgeX Therapeutics' history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume